Life Sciences RIM Platforms
Growth Webinar - Connected CEO: Intelligence Revolution
A leadership perspective from David Frigstad, Chairman & CEO, Frost & Sullivan.
Every leadership team has a strategy. Most have identified the right growth opportunities. Many have invested heavily in technology, AI, innovation, and transformation. Yet nearly 70% of strategic transformations fail to create lasting business value.
Why?
Because the real challenge is no longer strategy, it is implementation.
You can also explore our latest whitepaper titled "The Connected CEO: Leading Through the Intelligence Revolution".
You can join our exclusive webinar "Connected CEO | Top 10 Strategic Imperatives for the Intelligence Revolution: The Forces Shaping Your Future". on September 23rd, 2026, 9:00 AM PT to learn more.
- Align your strategy with laboratory product purchasing megatrends.
- Which product categories are shaping procurement decisions?
- Identify key innovation drivers in antibody-drug conjugates (ADCs).
- Adopt scalable biologics production to gain a competitive advantage.
- Capitalize on AI-enabled genomic workflow systems to gain an edge.
- Integrate laboratory information management systems and grow.
Introducing Frost & Sullivan’s Healthcare and Life Sciences LinkedIn Page
Transformation Growth Perspectives
Explore our growth-oriented whitepapers that translate industry disruption and strategic imperatives into actionable growth opportunities, competitive benchmarking, companies-to-action, and best practices to accelerate performance and drive sustainable competitive advantage.
Explore Executive Perspectives on Business Transformation
Interview with Tamanna Singh
Reimagining Menopause Care in India: Advancing Evidence-based and Personalized Care
Tamanna Singh
Founder & CEO | Menoveda
Interview with Randall Lipps
Transforming Medication Management: Advancing Autonomous Pharmacy Through AI and Connected Intelligence
Randall Lipps
Chairman, CEO, & Founder | Omnicell
Interview with Martin Heinz
Driving Manufacturing Intelligence: How iTAC Is Building Scalable, Integrated MES and Digital Twin Capabilities Across Industries
Martin Heinz
CEO | iTAC Software AG
Interview with Harshit Jain
Transforming Healthcare Marketing Through AI, EHR Intelligence, and Platform Innovation
Harshit Jain
Founder & Global CEO | Doceree
Interview with Eron Kelly
From AI Assistance to Agentic Execution: A Conversation on the Future of Data-driven Healthcare
Eron Kelly
CEO | ConcertAI
Navigating Transformation – Middle East (July 2026 Edition)
How can your organization thrive amidst the transformation of the ever-evolving NG911 and 5G industries?
Next Generation 911 in the United States
- How can you address growth gaps to outperform competitors in public safety?
- Capitalize on key prospects by aligning organizational design with innovations.
- Identify opportunities reshaping the next generation 911 (NG911) landscape.
Private 5G Network Landscape
- Are you equipped with new technologies to thrive amidst transformation?
- Maximize growth by harnessing networks to enhance performance.
- Align your strategy with megatrends reshaping private 5G networks.
Examine growth prospects in clinical ambient AI, behavioral health management, and conversational AI.

Learn more

Learn more

Learn more
Frost & Sullivan Brand and Demand Solutions

Capture growth across landscapes like conversational AI, revenue cycle management (RCM), and behavioral health management.
The Growth Innovation Leadership Council
How can your team grow rapidly in the ABM platform, content delivery network, and cloud service industries?
Frost & Sullivan welcomed more than 2,000 business leaders, policymakers, investors, academics and innovators to the 20th Growth, Innovation and Leadership (GIL) Summit in China, held August 4–5 at the Jing An Shangri-La in Shanghai.
Coinciding with Frost & Sullivan’s 65th anniversary, the summit featured more than 300 speakers and 150 keynote presentations and panel discussions. Topics included artificial intelligence, advanced manufacturing, semiconductors, life sciences, consumer markets and investment - highlighting the forces reshaping global competitiveness and transformational growth.
The event combined a flagship plenary programme with 10 parallel forums and the fifth edition of Frost & Sullivan’s New Investment Event, fostering collaboration across business, finance, government, academia and research.
Frost & Sullivan: 65 Years of Identifying Growth Opportunities in Healthcare and Life Sciences
Helping Organizations Prepare for the Coming Transformation and Create Growth Opportunities Since 1961
Check out our exclusive infographic that explores detailed growth opportunities across healthcare AI & cloud technologies, healthcare RCM & telehealth, healthcare cybersecurity & patient engagement solutions, medical imaging informatics, cardiovascular, neurology, & surgical navigation, patient monitoring & medical wearables, point-of-care testing, laboratory automation, personalized therapies, and contract pharmaceutical services.
Frost & Sullivan Launches New Industry-tuned AI Brand Equity and Industry Presence Advisory Service Powered by Optivara
Frost & Sullivan today announced the launch of its AI Brand Equity and Market Presence service, powered by Optivara. This service enables companies to understand how they appear across AI answer engines, how they compare to competitors, their competitive placement by funnel stage, and whether AI-generated market narratives reflect the position they have worked to build.
The service combines Optivara’s AI industry-tuned market presence platform with Frost & Sullivan’s industry expertise, analyst insights, and subject-matter expert validation. Clients receive a market presence benchmark, a competitive peer map, an AI-answer narrative review, a source diagnosis, and a detailed SWOT analysis. From that, an actionable roadmap to better control AI brand dynamics and drive demand is developed and implemented.
Reimagining Healthcare Infrastructure: Why ASCs Are Becoming the New Centre of Care
Healthcare delivery is undergoing one of its most significant structural shifts in decades, with ambulatory surgical centres (ASCs) evolving from a source of peripheral capacity relief to a core pillar of future healthcare infrastructure.
The Next Phase of Pharmaceutical Industry Growth: Key Megatrends to Watch in 2026
The global pharmaceutical industry covers the discovery, development, and commercialization of medicines, with large molecules driving most incremental growth while small molecules continue to provide a stable revenue base. Right now, the industry is going through a major shift toward cardiometabolic and oncology therapies, led by GLP-1 platforms and antibody-drug conjugates (ADCs).
From Scarce Ingredient to Scalable Functional Commodity: Scaling Ergothioneine for Commercial Success
Ergothioneine (EGT) is gaining industry attention as demand expands across functional skincare, oral supplements, nutraceutical fortification, and food preservation. Improvements in biosynthesis are making EGT more commercially accessible by overcoming earlier supply and scalability limitations that restricted its use to premium applications.
EdgeConneX Receives the Global AI High-density Infrastructure Technology Innovation Leadership Recognition for Excellence in AI-optimized Data Center Infrastructure
As organizations race to deploy increasingly sophisticated AI workloads, the demand for scalable, high-density digital infrastructure has never been greater. EdgeConneX is meeting that challenge by delivering AI-optimized data centers designed to support the next generation of artificial intelligence, high-performance computing (HPC), and cloud innovation.
Check out the latest news covering key industry developments and major company highlights to stay up-to-date in the healthcare and life sciences landscape.
- Pharma sector doubles down on AI amid hopes of slashing costs, timelines
- Medtronic boosts fiscal 2027 forecasts on heart device demand
- AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial
- Obesity battle heats up again as Novo claws way back into race with Lilly
- FTC probes health records giant Epic Systems, sources say
Frost & Sullivan Institute
Click Here to explore our latest blog on "Where Can Investments in Women’s Health Lead Us Tomorrow?".
Click Here to explore our latest blog on "AI Solutions Driving Disease Outbreak Predictions".
CUSTOMER ENGAGEMENT NEWSLETTER
Strategies and Tactics for Extraordinary Times
Subscribe Now to the monthly newsletter to explore major articles, insights, spotlight videos, upcoming events, council info and more.
THE INNOVATION NEWSLETTER
Inspiration and Best Practices to Help You Maximize Growth
Subscribe Now to the quarterly newsletter to access new articles, insights, spotlight blogs, upcoming events, council info and more.
Capture growth prospects across RNA therapy and neurogeneration landscapes.
Frost Growth Expert Network
Explore a wide range of Growth Webinars and Growth Podcasts highlighting emerging opportunities in the healthcare and life sciences landscape.
Dates: 17 – 19 September 2026
Venue: Bombay Exhibition Center, Goregaon (E), Mumbai
Medical Fair India is an international trade fair, exhibition, and conference for hospitals, health centres, and clinics. It serves as a world-class platform for industry engagement, innovation, and collaboration. The show receives strong institutional support from leading industry associations and key healthcare stakeholders, including policymakers, innovators, medical device manufacturers, hospitals, tech start-ups, and researchers.
Oman Health Exhibition
Dates: 21 – 23 September 2026
Venue: Oman Convention & Exhibition Centre
Oman Health Exhibition is an international event connecting local patients with world-class healthcare expertise. It offers visitors the unique opportunity to consult with leading international doctors, explore advanced medical services, and discover the latest healthcare innovations and technologies. Bringing together global medical professionals, healthcare organisations, and the public, the event serves as a bridge between Oman’s growing healthcare sector and the best international medical care and solutions available today.
CDMO Live Americas
Dates: October 19-21, 2026
Venue: Boston
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series. CDMO Live connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Future Health Summit
Dates: 20 – 22 October 2026
Venue: ADNEC Centre, Abu Dhabi
The Abu Dhabi Future Health Summit 2026, hosted by Future Health and the Department of Health – Abu Dhabi, takes place 20–22 October 2026 at ADNEC Centre Abu Dhabi. Bringing together global healthcare leaders, innovators, researchers, investors, and policymakers, the Summit will showcase advances in precision health, AI, longevity, and life sciences, while fostering insights, collaboration, partnerships, and healthcare transformation.
Global Health Exhibition
Dates: 26th - 29th October 2026
Venue: Malham, Riyadh, Saudi Arabia.
Established in 2018, Global Health Exhibition (GHE) is Saudi Arabia’s premier platform for driving healthcare transformation and innovation. Positioned as the global stage for healthcare evolution, GHE serves as a strategic meeting point for the world’s healthcare innovators, investors, and leaders. Organised by Tahaluf, a strategic alliance between Informa PLC, the Saudi Arabian Federation for Cyber Security and Programming (SAFCSP), and the Events Investment Fund (EIF), the event plays a pivotal role in advancing the Kingdom’s Vision 2030 Health Sector Transformation Program.
Hosted at the Riyadh Exhibition & Conference Center (Malham), GHE showcases groundbreaking technologies, including AI in diagnostics, genomic medicine, and telemedicine, while fostering public-private partnerships to reshape the future of healthcare in Saudi Arabia and beyond. Recognised for its excellence, GHE is an award-winning show, having been honored with the EN Awards for Best Trade Show over 10,000 SQM for its 2025 edition and previously awarded the AEO Best International Show – Middle East & Africa.
.
Bio Middle East
Dates: 14th to 16th December 2026
Venue: Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
BIO Middle East is the region’s dedicated biotechnology event, bringing together biotech innovators, pharmaceutical leaders, investors, researchers and policymakers. Taking place in Riyadh, Saudi Arabia, the event focuses on advancing biotechnology, biomanufacturing, precision medicine, investment and R&D partnerships, creating opportunities for collaboration and business growth across the Middle East and beyond.
The 20th Frost & Sullivan Global Growth, Innovation, and Leadership Summit and the 5th New Investment Event
Dates: 4-5 August 2026
Venue: Shanghai, China
On August 4-5, 2026, the 20th Frost & Sullivan Global Growth, Innovation and Leadership Summit and the 5th New Investment Event will have its grand opening at the Shangri La Hotel in Jing'an, Shanghai. This will also mark the 20th year milestone for Frost & Sullivan China to continue building on an international high-end communication platform for enterprises across China as well as the rest of the world.
CDMO Live Europe
Dates: May 19-21, 2026
Venue: Rotterdam
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series. CDMO Live connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Medical Fair India 2026
Dates: 17 – 19 September 2026
Venue: Bombay Exhibition Center, Goregaon (E), Mumbai
Medical Fair India is an international trade fair, exhibition, and conference for hospitals, health centres, and clinics. It serves as a world-class platform for industry engagement, innovation, and collaboration. The show receives strong institutional support from leading industry associations and key healthcare stakeholders, including policymakers, innovators, medical device manufacturers, hospitals, tech start-ups, and researchers.
CDMO Live Americas
Dates: October 19-21, 2026
Venue: Boston
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series. CDMO Live connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Dates: May 19-21, 2026
Venue: Rotterdam
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series that connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Register Now
Dates: October 19-21, 2026
Venue: Boston
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series that connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Register Now
Dates: 17 – 19 September 2026
Venue: Bombay Exhibition Center, Goregaon (E), Mumbai
Medical Fair India is an international trade fair, exhibition, and conference for hospitals, health centres, and clinics. It serves as a world-class platform for industry engagement, innovation, and collaboration. The show receives strong institutional support from leading industry associations and key healthcare stakeholders, including policymakers, innovators, medical device manufacturers, hospitals, tech start-ups, and researchers.
Register Now
Growth
Let's Talk About Your Project
Examine she brother prudent add day ham. Far stairs now coming bed oppose hunted become his. You zealously departure had procuring suspicion. Books whose front would purse if be do decay. Quitting you way formerly disposed perceive ladyship are.

